LAUREN WALKER

Has grant

Senior Clinical Lecturer

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment

Open Date: 2021-01-04

Close Date: 2023-01-03

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Janice Schwartz

Professor

University of California, San Francisco

UNITED STATES

View details

Lauren Walker

UNITED KINGDOM

View details

Danushka Bollegala

University of Liverpool

UNITED KINGDOM

View details

Petra A. Thürmann

Private Universität Witten/Herdecke gGmbH

GERMANY

View details

Robert Waugh

University of Southampton

UNITED KINGDOM

View details

David Le Couteur

Professor of Geriatric Medicine

University of Sydney

AUSTRALIA

View details

Annamaria Vezzani

Head of Experimental Neurology Laboratory

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Girvan Burnside

Reader

University of Liverpool

UNITED KINGDOM

View details

Mirko Petrovic

Full Professor, Chairman of the Department

Ghent University

BELGIUM

View details

Sean Ewings

Associate Professor of Medical Statistics

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

LAUREN WALKER

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (12)

Addressing the gaps in evaluation of new drugs for older adults: Strategies from the International Union of Basic and Clinical Pharmacology (IUPHAR) Geriatric Committee

Incorporating transgender and nonbinary participants in phase 1 clinical drug trials: Current knowledge gaps and considerations

Cardiovascular risk estimation in rural psychiatric inpatient populations: Cross-sectional preliminary study

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

A European cross-sectional survey to investigate how involved doctors training in clinical pharmacology are in drug concentration monitoring

Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance

Triple antithrombotic therapy and dual therapy – What is the evidence base?

Paediatric polypharmacy and deprescribing: the views of UK healthcare professionals

An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2

High‐mobility group box 1 as a predictive biomarker for drug‐resistant epilepsy: A proof‐of‐concept study

The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity

Collaborators (10)

Janice Schwartz

Lauren Walker

Danushka Bollegala

Petra A. Thürmann

Robert Waugh

David Le Couteur

Annamaria Vezzani

Girvan Burnside

Mirko Petrovic

Sean Ewings

Make your next move.